RETRACTION: Top 100 cited articles on anosmia and COVID‐19: a bibliometric analysis

Abstract

ObjectivesWith the exponential growth of literature on coronavirus disease 2019 (COVID‐19), we undertook a bibliometric analysis of the top 100 most cited COVID‐19‐related articles in anosmia, to identify high‐impact studies relating to anosmia as a symptom of early COVID‐19 infection.MethodsThe top 100 cited papers were searched on the Thompson Reuters Web of Science database. We performed a title‐specific search using (“anosmia,” “loss of smell,” “olfactory dysfunction,” “hyposmia,” or “reduced smell”) and (“COVID‐19,” “SARS‐CoV‐2,” or “new coronavirus”) as our search terms. The top 100 most cited English‐language articles were obtained and reviewed.ResultsFrom 2020 to 2022, our search yielded a total of 2,176 articles. Bibliometric analysis of the top 100 full manuscripts found that the most cited article had a citation count of 1,378 and the paper acknowledged that sudden anosmia or ageusia were common presentations in COVID‐19 patients with no nasal symptoms. The top 100 papers were published in 54 journals and were cited 12,980 times. The highest proportion of first authors affiliated instituted in the United States, and the publications from the United Kingdom and France were the most influential. The European Archives of Oto‐Rhino‐Laryngology was the journal with the highest number of total citations (1,558).ConclusionThis study provided valuable data on the top 100 most cited COVID‐19 anosmia‐related articles published to date.